Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · IEX Real-Time Price · USD
67.67
-0.05 (-0.07%)
May 20, 2024, 12:37 PM EDT - Market open
Gilead Sciences Revenue
Gilead Sciences had revenue of $27.45B in the twelve months ending March 31, 2024, with 1.51% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $6.69B with 5.26% year-over-year growth. In the year 2023, Gilead Sciences had annual revenue of $27.12B, a decrease of -0.60%.
Revenue (ttm)
$27.45B
Revenue Growth
+1.51%
P/S Ratio
3.07
Revenue / Employee
$1,525,000
Employees
18,000
Market Cap
84.29B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 27.12B | -165.00M | -0.60% |
| Dec 31, 2022 | 27.28B | -24.00M | -0.09% |
| Dec 31, 2021 | 27.31B | 2.62B | 10.60% |
| Dec 31, 2020 | 24.69B | 2.24B | 9.98% |
| Dec 31, 2019 | 22.45B | 322.00M | 1.46% |
| Dec 31, 2018 | 22.13B | -3.98B | -15.24% |
| Dec 31, 2017 | 26.11B | -4.28B | -14.09% |
| Dec 31, 2016 | 30.39B | -2.25B | -6.89% |
| Dec 31, 2015 | 32.64B | 7.75B | 31.13% |
| Dec 31, 2014 | 24.89B | 13.69B | 122.19% |
| Dec 31, 2013 | 11.20B | 1.50B | 15.46% |
| Dec 31, 2012 | 9.70B | 1.32B | 15.70% |
| Dec 31, 2011 | 8.39B | 435.97M | 5.48% |
| Dec 31, 2010 | 7.95B | 938.04M | 13.38% |
| Dec 31, 2009 | 7.01B | 1.68B | 31.40% |
| Dec 31, 2008 | 5.34B | 1.11B | 26.14% |
| Dec 31, 2007 | 4.23B | 1.20B | 39.78% |
| Dec 31, 2006 | 3.03B | 997.74M | 49.19% |
| Dec 31, 2005 | 2.03B | 703.78M | 53.13% |
| Dec 31, 2004 | 1.32B | 456.76M | 52.63% |
| Dec 31, 2003 | 867.86M | 401.07M | 85.92% |
| Dec 31, 2002 | 466.79M | 233.02M | 99.68% |
| Dec 31, 2001 | 233.77M | 38.21M | 19.54% |
| Dec 31, 2000 | 195.56M | 26.58M | 15.73% |
| Dec 31, 1999 | 168.98M | 17.86M | 11.82% |
| Dec 31, 1998 | 151.12M | 18.86M | 14.26% |
| Dec 31, 1997 | 132.26M | 98.84M | 295.75% |
| Dec 31, 1996 | 33.42M | 28.50M | 578.99% |
| Mar 31, 1995 | 4.92M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CVS Health | 360.94B |
| McKesson | 308.95B |
| Cigna | 206.00B |
| HCA Healthcare | 66.72B |
| Bristol-Myers Squibb Company | 45.53B |
| GSK | 39.41B |
| Becton, Dickinson and Company | 19.72B |
| Regeneron Pharmaceuticals | 13.10B |
GILD News
- 2 days ago - Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis - Business Wire
- 6 days ago - Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy - Business Wire
- 10 days ago - Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program - Business Wire
- 10 days ago - Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program - Business Wire
- 11 days ago - Will Gilead Sciences Stock Recover To Its Pre-Inflation Shock Highs Of Around $75? - Forbes
- 13 days ago - Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024 - Business Wire
- 19 days ago - Gilead Sciences to Present at Upcoming Investor Conferences - Business Wire
- 24 days ago - FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV - Business Wire